top of page

Term Life Insurance After Colon Polyps: What Underwriters Usually Want to See

Written by: Jeff Schmidt | Licensed Insurance Broker | CarePro Insurance Content reviewed for accuracy. Not legal, tax, or financial advice.

Most underwriting questions after colon polyps come down to what was found, whether it was removed, and whether you're following the recommended surveillance schedule.

  • Instant online pricing

  • No phone calls required

  • No pressure from agents

Colon Polyps: Type + Follow-Up

Pathology (benign vs higher-risk findings) and number of polyps

Dates: colonoscopy timing, removal, and follow-up plan

Symptoms, family history, and any related GI diagnoses

A history of colon polyps sounds more alarming than it often is in underwriting terms, and many applicants qualify for term life coverage after polyps are removed and appropriate follow-up is documented. The starting point for any underwriting review of this history is the type of polyp that was found, because not all polyps carry the same risk profile. Adenomatous polyps - commonly called adenomas - have neoplastic potential, meaning they can progress toward colorectal cancer if they grow and are left in place, which is why their discovery and removal is clinically significant. Hyperplastic polyps, by contrast, particularly those located in the rectosigmoid region, are generally considered low-risk findings with minimal malignant potential, and most underwriters treat a clean colonoscopy that removed only rectosigmoid hyperplastic polyps as close to a routine screening outcome. This fundamental distinction between adenoma and hyperplastic polyp is usually the first question underwriters ask when this history appears on an application.

Within the adenoma category, additional features matter significantly to how the underwriting review proceeds. Polyp size is an independent risk factor: adenomas larger than one centimeter are associated with higher rates of high-grade dysplasia and are more likely to trigger intensive surveillance intervals, which underwriters treat as a severity signal. The histological subtype is another important distinction - tubular adenomas are the most common and least aggressive subtype, tubulovillous and villous adenomas carry higher malignant potential, and sessile serrated adenomas or sessile serrated polyps (SSA/SSP) represent a separate and increasingly recognized pathological category that deserves special mention. SSA/SSP lesions are more likely to be flat and difficult to identify endoscopically, have higher rates of incomplete resection than pedunculated polyps, and are associated with the serrated neoplasia pathway that leads to a specific subset of colorectal cancers. Some underwriters specifically probe whether the pathology report identified any SSA/SSP findings, because that category changes the risk picture beyond what a simple tubular adenoma finding would.

The recommended surveillance interval stated in the colonoscopy report or the gastroenterologist's follow-up plan is among the most underwriting-relevant pieces of information in this entire history, because it encodes the specialist's overall assessment of what was found. A ten-year return interval is the standard recommendation for a low-risk finding such as one or two small tubular adenomas without advanced features, and underwriters generally treat this as a routine outcome. A five-year interval indicates an intermediate finding such as three to four adenomas or one adenoma with low-grade dysplasia. A three-year interval indicates a higher-risk scenario such as five or more adenomas, a large adenoma, an adenoma with villous features, or high-grade dysplasia. A one-year interval signals that the gastroenterologist found something requiring very close monitoring, and carriers treat that recommendation as a prompt to request documentation and understand the finding in full before proceeding.

Adherence to the recommended surveillance schedule is evaluated independently of the original finding. An applicant who completed a colonoscopy that found polyps, had them removed, received a three-year return recommendation, and then completed that follow-up on schedule with normal results presents a picture of a managed and monitored history. An applicant who received a one-year return recommendation and has not yet completed the follow-up - or who skipped a scheduled colonoscopy - presents a more complicated picture regardless of how benign the original pathology appeared. Family history of colorectal cancer is evaluated as an independent risk layer that can affect underwriting even when the applicant's own findings were entirely benign, because a first-degree relative with colorectal cancer elevates the applicant's baseline risk and may prompt questions about whether the screening schedule accounts for that family history. Documented hereditary syndromes such as Lynch syndrome are evaluated as separate and more significant factors.

Before you apply, gather the key details that underwriters will want: the date of the most recent colonoscopy, the type and number of polyps found, the pathology report findings if you have them or at minimum what you were told by your doctor, whether all polyps were fully removed, and the recommended follow-up interval. If you had a surveillance colonoscopy after the initial finding, having those results available is equally useful - a clear surveillance study showing no new polyps substantially strengthens the underwriting picture. Cases where records show benign pathology, complete resection, and an active and on-track surveillance schedule are among the more straightforward to underwrite for a condition that initially appears concerning to applicants who are not familiar with how the risk categories work.

For the main instant/no-exam term life guide and how underwriting works, see: https://www.careproinsurance.com/instant-term-life-insurance

The content on this page is informational and educational only; it is not professional advice. Quotes are estimates; final eligibility, rates, and requirements depend on underwriting and policy issuance.

Frequently Asked Questions

Can I get term life insurance after colon polyps?

Often, yes. Many applicants qualify after benign polyps are removed, especially with appropriate follow-up. The details and timing influence underwriting outcomes.

Do benign polyps affect life insurance premiums?

Sometimes there's little to no impact, especially with a routine screening history. Higher-risk findings, multiple polyps, or recent unresolved follow-up can affect pricing or requirements.

What information do carriers ask for after colon polyps?

Commonly requested details include colonoscopy dates, number and type of polyps, pathology results, whether polyps were removed, and the recommended surveillance interval.

Will I need a medical exam because of colon polyps?

Not always. Some applicants still qualify for accelerated/no-exam paths, but carriers may request records to confirm pathology and follow-up depending on timing and findings.

Does family history of colon cancer matter?

It can. Carriers may consider family history as part of the overall risk profile and may also look at whether you're following recommended screening guidelines.

Does the number of adenomas found during a single colonoscopy affect underwriting even if all were removed?

Yes, the number of adenomas found at a single session directly affects the recommended surveillance interval and therefore the underwriting review. Finding one small tubular adenoma is treated differently than finding five or more adenomas at once, even if all were successfully removed and confirmed benign on pathology. Carriers frequently ask specifically how many polyps were identified and removed, so having that detail from the procedure report or your gastroenterologist's notes is useful before applying.

What if my colonoscopy was recent and I have not yet had the recommended follow-up?

A recent colonoscopy with benign findings and a future surveillance colonoscopy not yet due is generally manageable as long as the recommended interval is longer than one year. If the recommended interval was shorter - typically indicating higher-risk features - some carriers may prefer to see that follow-up completed and showing clear results before finalizing a decision. Applying after the follow-up is complete with normal results tends to produce a better outcome than applying during the waiting period.

Does the method of polyp removal affect how underwriters view the finding?

It can, particularly for larger or more complex lesions. Standard polypectomy of a well-visualized pedunculated polyp with documented clean margins at the time of removal is the most straightforward scenario. Piecemeal resection of a large or flat sessile lesion - where the endoscopist removed it in multiple pieces rather than as a single specimen - may prompt questions about whether a subsequent surveillance colonoscopy confirmed complete removal with no residual tissue. If that confirmation exists in the medical records, it significantly supports a cleaner underwriting picture.

bottom of page